Atlas Trials

Cell>Point LLC

5 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Cell>Point LLC

RecordFirmDate
Efficacy and Saftey Study of 99mTc-ECDG in the Evaluation of Coronary Artery Disease (CAD) (NCT01899833)Cell>Point LLC2025-05-10
A Phase 3 Study of 99mTC-EC-DG SPECT/CT Versus PET/CT in Lung Cancer (NCT01394679)Cell>Point LLC2025-05-01
A Single Center Study to Establish the Imaging Protocol of 99mTc-EC-DG in Evaluating the Presence and Severity of Coronary Artery Disease (CAD) (NCT01778218)Cell>Point LLC2013-01-01
Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC) (NCT00864110)Cell>Point LLC2010-04-01
Phase 2 Study Comparing 99mTc-EC-DG SPECT/CT With 18F FDG PET/CT in Patients With Non-small Cell Lung Cancer (NSCLC) (NCT00865319)Cell>Point LLC2009-06-01

Track Cell>Point LLC automatically

Every clearance here is in the API, with alerts when new ones post.